Skip to content

Zonulo-hyaloido-vitrectomy for Malignant Glaucoma

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02613143
Enrollment
10
Registered
2015-11-24
Start date
Unknown
Completion date
Unknown
Last updated
2015-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Glaucoma

Keywords

malignant glaucoma, zonulo-hyaloido-vitrectomy

Brief summary

The purpose of this study is to assess the zonulo-hyaloido-vitrectomy for malignant glaucoma through an anterior approach.

Interventions

None listed

Sponsors

Wenzhou Medical University
Lead SponsorOTHER

Study design

Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients who underwent the zonulo-hyaloido-vitrectomy for malignant glaucoma through an anterior approach

Exclusion criteria

* systemic disease or inflammation

Design outcomes

Primary

MeasureTime frameDescription
intraocular pressure3 yearsThe intraocular pressure is measured by the non-contact tonometer.

Countries

China

Contacts

Primary ContactXixia Ding, Ph.D
dingxixiaxc@163.com+86 13780148109

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026